tace epirubicin
什麼是TACE? 肝動脈栓塞化學療法(TACE) 是治療肝癌的一種療法。透過阻斷血液供給腫瘤. （癌症） ... ,Purpose: To compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI) plus mitomycin C (M) and ... ,2018年3月8日 — Recently, epirubicin has been widely applied as anticancer agent for TACE in HCC. Several previous studies suggested that epirubicin might be ... ,2017年8月1日 — Methods: Patients with unresectable HCC were randomized 1:1 to receive TACE with miriplatin or epirubicin in lipiodol. The primary endpoint ... ,2010年9月7日 — ELM-TACE is safe and effective treatment for unresectable HCC and is associated with low frequency of postembolization syndrome and ... ,2014年1月20日 — 經導管肝動脈栓塞術(TAE/TACE)治療肝細胞癌」. 醫學新知 ... 劑(常用如Doxorubicin, Epirubicin, 過一小時和抗癌劑沖泡(Doxorubicin/. Mitomycin-. ,TACE was performed with a mixture of lipiodol, epirubicin hydrochloride, and mitomycin followed by microspheres as devascularizing material. Local external ... ,為肝癌，經行政院衛生署統計處公佈為國人十大癌症死因之一。而經. 導管動脈化學藥物栓塞治療（Transcatheter arterial chemoembolization,T.A.C.E.）為主要有效 ... ,動脈化療栓塞療法(Transarterial chemoembolization, TACE)或是動脈栓塞 ... hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin,.
| 相關軟體 VMware Workstation Pro 資訊 | |
|---|---|
 tace epirubicin 相關參考資料
(TACE) - the University Health Network
什麼是TACE? 肝動脈栓塞化學療法(TACE) 是治療肝癌的一種療法。透過阻斷血液供給腫瘤. （癌症） ... https://www.uhn.ca Comparison of local control effects of superselective ... - PubMed
Purpose: To compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI) plus mitomycin C (M) and ... https://pubmed.ncbi.nlm.nih.go Efficacy and safety of epirubicin applied in transcatheter ...
2018年3月8日 — Recently, epirubicin has been widely applied as anticancer agent for TACE in HCC. Several previous studies suggested that epirubicin might be ... https://www.cancerjournal.net Transarterial chemoembolization with miriplatin vs. epirubicin ...
2017年8月1日 — Methods: Patients with unresectable HCC were randomized 1:1 to receive TACE with miriplatin or epirubicin in lipiodol. The primary endpoint ... https://pubmed.ncbi.nlm.nih.go Transcatheter arterial chemoembolization with epirubicin ...
2010年9月7日 — ELM-TACE is safe and effective treatment for unresectable HCC and is associated with low frequency of postembolization syndrome and ... https://pubmed.ncbi.nlm.nih.go Untitled
2014年1月20日 — 經導管肝動脈栓塞術(TAE/TACE)治療肝細胞癌」. 醫學新知 ... 劑(常用如Doxorubicin, Epirubicin, 過一小時和抗癌劑沖泡(Doxorubicin/. Mitomycin-. http://www.doctor.org.tw 國家圖書館期刊文獻資訊網中文期刊篇目系統：摘要
TACE was performed with a mixture of lipiodol, epirubicin hydrochloride, and mitomycin followed by microspheres as devascularizing material. Local external ... http://readopac3.ncl.edu.tw 肝細胞惡性腫瘤的經導管動脈化學藥物栓塞治療(T.A.C.E)介紹
為肝癌，經行政院衛生署統計處公佈為國人十大癌症死因之一。而經. 導管動脈化學藥物栓塞治療（Transcatheter arterial chemoembolization,T.A.C.E.）為主要有效 ... http://depart.femh.org.tw 高雄榮民總醫院肝細胞癌診療指引
動脈化療栓塞療法(Transarterial chemoembolization, TACE)或是動脈栓塞 ... hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin,. https://wwwfs.vghks.gov.tw |